Filing Details
- Accession Number:
- 0001209191-20-057066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 21:33:15
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 21:33:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1246406 | Bradford Crutchfield | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2020-11-02 | 10,504 | $1.16 | 11,467 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,500 | $135.29 | 9,967 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 6,604 | $136.06 | 3,363 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,200 | $136.97 | 2,163 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 800 | $138.40 | 1,363 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 400 | $139.25 | 963 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2020-11-03 | 6,496 | $1.16 | 7,459 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 200 | $135.42 | 7,259 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 2,198 | $136.60 | 5,061 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 3,898 | $137.56 | 1,163 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 200 | $138.43 | 963 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-02 | 10,504 | $0.00 | 10,504 | $1.16 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-03 | 6,496 | $0.00 | 6,496 | $1.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 653,496 | 2027-02-03 | No | 4 | M | Direct | |
| 647,000 | 2027-02-03 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $134.63 to $139.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.65 to $136.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.65 to $137.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $138.00 to $138.81. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $139.23 to $139.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.09 to $135.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.09 to $137.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $137.11 to $138.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $138.20 to $138.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This option, originally for 800,000 shares, of which 146,504 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- This option, originally for 800,000 shares, of which 153,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Billionaire Hedge Funds
